Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511.
Norman, M.H., Andrews, K.L., Bo, Y.Y., Booker, S.K., Caenepeel, S., Cee, V.J., D'Angelo, N.D., Freeman, D.J., Herberich, B.J., Hong, F.T., Jackson, C.L., Jiang, J., Lanman, B.A., Liu, L., McCarter, J.D., Mullady, E.L., Nishimura, N., Pettus, L.H., Reed, A.B., Miguel, T.S., Smith, A.L., Stec, M.M., Tadesse, S., Tasker, A., Aidasani, D., Zhu, X., Subramanian, R., Tamayo, N.A., Wang, L., Whittington, D.A., Wu, B., Wu, T., Wurz, R.P., Yang, K., Zalameda, L., Zhang, N., Hughes, P.E.(2012) J Med Chem 55: 7796-7816
- PubMed: 22897589 
- DOI: https://doi.org/10.1021/jm300846z
- Primary Citation of Related Structures:  
4FLH - PubMed Abstract: 
The phosphoinositide 3-kinase family catalyzes the phosphorylation of phosphatidylinositol-4,5-diphosphate to phosphatidylinositol-3,4,5-triphosphate, a secondary messenger which plays a critical role in important cellular functions such as metabolism, cell growth, and cell survival ...